Guidelines for the management of actinic keratoses
Guidelines for the management of actinic keratoses
复制标题
DOI：
10.1111/j.1365-2133.2006.07692.x
复制
发表时间：
2007-02-01
影响因子：
10.3
通讯作者：
Hughes, B. R.
中科院分区：
文献类型：
--
作者：
de Berker, D.;McGregor, J. M.;Hughes, B. R.
这些指导方针源于英国光生物学小组（BPG）在1999年举行的一次共识会议。在这次会议之后，作者之一（J.M.M.）获英国皮肤科医生协会治疗指引及审核小组委员会邀请，为光化性角化病的管理草拟指引。从1966年起，使用检索词“日光性角化病”和“光化性角化病”在Medline中寻找相关证据。根据1966年后出版物中的参考文献，对其他和早期文献进行了综述。所有明显相关的文章均独立于出版物的性质进行审查。所得出的证据的质量已得到说明。全国门诊医疗调查（美国）用于局部化疗的进一步数据。BPG研讨会的贡献者对论文进行了审查和讨论（见致谢）。建议尽可能以证据为基础。建议的强度与证据的质量相结合。建议的力度包括考虑明显的成本效益和实际考虑。证据质量反映了提供疗效数据的试验结构的性质。
These guidelines stemmed from a consensus meeting held by the British Photobiology Group (BPG) in 1999. Following this meeting one of the authors (J.M.M.) was invited to draw up guidelines for the management of actinic keratoses by the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Relevant evidence was sought using the search terms 'solar keratosis' and 'actinic keratosis' in Medline from 1966 onwards. Additional and earlier literature was reviewed on the basis of references within post-1966 publications. All articles of apparent relevance were reviewed independently of the nature of the publication. The quality of the evidence elicited has been indicated. The National Ambulatory Medical Care Survey (U.S.A.) was used for further data on topical chemotherapy. Papers were reviewed and discussed by the contributors to the BPG Workshop (see Acknowledgments). Recommendations are evidence based where possible. Strength of recommendation is coupled with quality of evidence. Strength of recommendation includes consideration of apparent cost-benefit and practical considerations. Quality of evidence reflects the nature of the trial structure that provides data of efficacy.